Multiple Seeking Alpha items cover AbbVie’s planned acquisition of Apogee Therapeutics, including an M&A call transcript and a slideshow presentation. The materials present AbbVie’s perspective on the transaction and related business considerations, focusing on how the deal fits into AbbVie’s pipeline and strategy. They also reflect the standard structure of acquisition communications, including company commentary and discussion of deal rationale, potential opportunities from Apogee’s assets, and forward-looking expectations associated with closing and integration. While the provided sources do not include the full text of the transcript or slideshow details here, they indicate that AbbVie and relevant participants address the acquisition through both a live call format and accompanying slides. Together, the two items suggest coordinated messaging for investors: one document summarizes the Q&A and spoken discussion, while the other provides an at-a-glance presentation of key transaction points. Overall, the sources agree on the subject—AbbVie’s acquisition of Apogee Therapeutics—and present it through investor-focused materials intended to explain the deal and its anticipated impact.